Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A new phase 3 trial reveals that combining enzalutamide and leuprolide significantly improves overall survival for men with ...

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of ...

Former President Joe Biden, 82, completed a round of radiation therapy for aggressive prostate cancer. He received treatment ...

Biden's daughter posted an Instagram video of her father at Penn Medicine ringing a bell, which is done to mark the end of a ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.